Thanks to MBOLDmn for featuring Onego Bio in the latest #ProteinInnovator series. In this conversation, our CFO, Tom Ferguson, shares our vision for Bioalbumen® and why we believe the future isn't about replacing eggs. It's about giving the food industry a reliable second source of egg protein that will contribute to long-term supply stability. During the event, Tom also pitched Onego Bio in the Protein Innovation Pitch Slam, where we were honored to be selected as the 2025 winner.
Meet Tom Ferguson and Onego Bio in our latest installment of MBOLDmn’s #proteininnovator video series. Headquartered in Helsinki, Onego Bio produces Bioalbumen®, a non-animal egg protein made from fermentation and was the Protein Innovation Pitch Slam judges' winner at Bridge2Food North America in 2025. Stay tuned for details and join us for the 2026 Protein Innovation Pitch Slam by attending Bridge2Food North America in October. https://lnkd.in/gtpP5hZ4